Hosted on MSN29m
TD Cowen Downgrades Syros Pharmaceuticals (SYRS)Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback